Fresh Market Data
  • Investing News
  • Stock News
  • World News
  • Business News
Stock News

Bearish Warning: 3 Market Sentiment Indicators You Can’t Ignore

by April 22, 2025
April 22, 2025

In this video, market sentiment, investor psychology, and stock market trends take center stage as David Keller, CMT, shares three powerful sentiment indicators that he tracks every week. He explains how the values are derived, what the current readings say about the market environment in April 2025, and how these levels compare to past bull markets and bear markets. If you’re looking for a sentiment playbook to navigate these markets, this analysis will give you the edge.

This video originally premiered on April 21, 2025. Watch on StockCharts’ dedicated David Keller page!

Previously recorded videos from Dave are available at this link.

previous post
DP Trading Room: Long-Term Outlook for Bonds
next post
Three Stocks to Watch This Earnings Week

Related Posts

Week Ahead: NIFTY Stays In Technically Challanging Environment;...

May 11, 2025

Recession Ahead? Sector Rotation Model Warns of Rising...

May 10, 2025

Where the Market Goes Next: Key Resistance Levels...

May 10, 2025

Investment Portfolio Feeling Stagnant? Transform Your Path Today

May 10, 2025

Which Will Hit First: SPX 6100 or SPX...

May 10, 2025

Confused by the Market? Let the Traffic Light...

May 10, 2025

The V Reversal is Impressive, but is it...

May 10, 2025

Don’t Buy Robinhood Stock… Until You See This...

May 9, 2025

The Unpredictable Stock Market: How to Make Sense...

May 8, 2025

Use This Multi-Timeframe MACD Signal for Precision Trades

May 8, 2025

Recent Posts

  • Web3 Leaders Gather in Toronto for Canada Crypto Week
  • Pan American to Buy MAG Silver in US$2.1 Billion Deal, Adding Juanicipio Mine to Portfolio
  • Missouri Set to Recognize Gold and Silver as Legal Tender, Critics Raise Implementation Concerns
  • Heaven’s Earthly Treasures: Behind the Metallurgy of the Papal Symbols
  • Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 FreshMarketData.com All Rights Reserved.

    Fresh Market Data
    • Investing News
    • Stock News
    • World News
    • Business News